Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

BioTech Weekly

Week 28 - Jul 7-13, 2025

14 Jul 2025

Description

📢 Industry Highlights in Biotech & Life Sciences 📢 From leadership changes to licensing deals and product launches, here's a roundup of recent developments shaping the future of healthcare innovation:Sources🔗 Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development🔗 Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer🔗 enGene Announces Board and Leadership Appointments to Support Commercial Readiness🔗 OTC Markets Group Welcomes Vaxart, Inc. to OTCQX🔗 UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health🔗 Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness🔗 ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors🔗 Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation🔗 Newly Elected Directors of Sinovac Hold the First Board Meeting#biotech #lifesciences #healthcareinnovation #leadership #drugdevelopment #clinicaltrials #biopharma #LinkedInNews💡 Follow the BioTech Weekly newsletter for more updates on biotech breakthroughs, regulatory milestones, and investment trends in life sciences.Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.